Cliff Holloway
Chief Business Officer @Ethris
Signup · Get unlimited contacts
WORK HISTORY
Chief Business Officer @Ethris
Munich, DE
ETHRIS is a highly experienced and innovative mRNA design and delivery platform company with a very attractive and competitive pipeline of therapeutic and vaccine drug candidates approaching clinical development. At its core, ETHRIS offers proprietary and highly differentiated mRNA modification and design technologies, lipidoid nanoparticle (LNP) and formulation platforms, cost-efficient and scalable GMP-compliant manufacturing and formulation processes as well as multi-route delivery capabilities, e.g. for intramuscular, inhaled or nasal drug delivery. A key and unique focus area of ETHRIS is the delivery of mRNA drugs to the upper and lower respiratory tract, in combination with a deep understanding of respiratory and infectious diseases and drug development.
EDUCATION
University of Nottingham
B.Pharm (Hons), Pharmacy
University of Nottingham
Ph.D, Medicinal Chemistry
ABOUT CLIFF HOLLOWAY
Executive management and Directorship positions within the Biopharmaceutical and ICT industries, resulting in dynamic career progression based on establishing international operations, monetising emerging technologies and restructuring of companies in the private and public sectors to improve commercial outcome. Specialties: Direct experience in establishing and negotiating technology partnerships, IP licensing, asset acquisitions, royalty agreements, joint ventures, equity investments and company mergers and acquisitions
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.